ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för sulfamethoxazole hydroxylamine. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

13 träffar

Bibliografisk träff 2010-03-11

Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine.

Bhusari S, Abouraya M, Padilla ML, Pinkerton ME, Drescher NJ, Sacco JC, Trepanier LA.

Arch Toxicol · research-article; journal article; research support, n.i.h., extramural · DOI 10.1007/s00204-010-0530-z

Bibliografisk träff 2010-01-01

Cytochrome b5 and NADH cytochrome b5 reductase: genotype-phenotype correlations for hydroxylamine reduction.

Sacco JC, Trepanier LA.

Pharmacogenet Genomics · research-article; journal article; research support, n.i.h., extramural · DOI 10.1097/fpc.0b013e3283343296

Bibliografisk träff 2006-02-13

Roles of endogenous ascorbate and glutathione in the cellular reduction and cytotoxicity of sulfamethoxazole-nitroso.

Lavergne SN, Kurian JR, Bajad SU, Maki JE, Yoder AR, Guzinski MV, Graziano FM, Trepanier LA.

Toxicology · clinical trial; journal article; research support, n.i.h., extramural · DOI 10.1016/j.tox.2006.01.018

Bibliografisk träff 2005-01-01

Exposure of mice to the nitroso metabolite of sulfamethoxazole stimulates interleukin 5 production by CD4+ T-cells.

Hopkins JE, Naisbitt DJ, Humphreys N, Dearman RJ, Kimber I, Park BK.

Toxicology · research support, non-u.s. gov't; journal article · DOI 10.1016/j.tox.2004.08.010

Bibliografisk träff 2001-08-01

Effect of lipopolysaccharide (LPS)-evoked host defense activation on hepatic microsomal formation and reduction of sulfamethoxazole hydroxylamine in the rat.

Cribb AE, McQuaid T, Renton KW.

Biochem Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/s0006-2952(01)00691-8

Bibliografisk träff 2001-05-01

Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo.

Naisbitt DJ, Gordon SF, Pirmohamed M, Burkhart C, Cribb AE, Pichler WJ, Park BK.

Br J Pharmacol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/sj.bjp.0704074

Bibliografisk träff 2000-06-01

Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals.

Schnyder B, Burkhart C, Schnyder-Frutig K, von Greyerz S, Naisbitt DJ, Pirmohamed M, Park BK, Pichler WJ.

J Immunol · research support, non-u.s. gov't; journal article · DOI 10.4049/jimmunol.164.12.6647

Bibliografisk träff 1999-10-01

Cytotoxicity of sulfonamide reactive metabolites: apoptosis and selective toxicity of CD8(+) cells by the hydroxylamine of sulfamethoxazole.

Hess DA, Sisson ME, Suria H, Wijsman J, Puvanesasingham R, Madrenas J, Rieder MJ.

FASEB J · research support, non-u.s. gov't; journal article · DOI 10.1096/fasebj.13.13.1688

Bibliografisk träff 1995-03-01

N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes.

Cribb AE, Spielberg SP, Griffin GP.

Drug Metab Dispos · journal article · DOI 10.1016/s0090-9556(25)06552-3

Bibliografisk träff 1994-08-01

The hydroxylamine of sulfamethoxazole and adverse reactions in patients with acquired immunodeficiency syndrome.

Lee BL, Delahunty T, Safrin S.

Clin Pharmacol Ther · clinical trial; research support, u.s. gov't, p.h.s.; randomized controlled trial; journal article · DOI 10.1038/clpt.1994.122

Bibliografisk träff 1991-09-01

Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity.

Cribb AE, Miller M, Leeder JS, Hill J, Spielberg SP.

Drug Metab Dispos · research support, non-u.s. gov't; journal article · DOI 10.1016/s0090-9556(25)08967-6

Bibliografisk träff 1991-02-01

Cellular toxicity of sulfamethoxazole reactive metabolites--I. Inhibition of intracellular esterase activity prior to cell death.

Leeder JS, Dosch HM, Spielberg SP.

Biochem Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/0006-2952(91)90629-j

Bibliografisk träff 1991-02-01

Cellular toxicity of sulfamethoxazole reactive metabolites--II. Inhibition of natural killer activity in human peripheral blood mononuclear cells.

Leeder JS, Nakhooda A, Spielberg SP, Dosch HM.

Biochem Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/0006-2952(91)90630-n